149 related articles for article (PubMed ID: 20472681)
21. A mouse model for glioma: biology, pathology, and therapeutic opportunities.
Holland EC
Toxicol Pathol; 2000; 28(1):171-7. PubMed ID: 10669005
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
[TBL] [Abstract][Full Text] [Related]
23. Lentiviral transfer of an inducible transgene expressing a soluble form of Gas1 causes glioma cell arrest, apoptosis and inhibits tumor growth.
López-Ornelas A; Mejía-Castillo T; Vergara P; Segovia J
Cancer Gene Ther; 2011 Feb; 18(2):87-99. PubMed ID: 20885451
[TBL] [Abstract][Full Text] [Related]
24. Applications of mouse glioma models in preclinical trials.
Hu X; Holland EC
Mutat Res; 2005 Aug; 576(1-2):54-65. PubMed ID: 16011838
[TBL] [Abstract][Full Text] [Related]
25. The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies.
Fueyo J; Gomez-Manzano C; Yung WK; Kyritsis AP
Neurology; 1998 Nov; 51(5):1250-5. PubMed ID: 9818841
[TBL] [Abstract][Full Text] [Related]
26. Sense p16 and antisense uPAR bicistronic construct inhibits angiogenesis and induces glioma cell death.
Nalabothula N; Lakka SS; Dinh DH; Gujrati M; Olivero WC; Rao JS
Int J Oncol; 2007 Mar; 30(3):669-78. PubMed ID: 17273768
[TBL] [Abstract][Full Text] [Related]
27. Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma.
Subashi E; Cordero FJ; Halvorson KG; Qi Y; Nouls JC; Becher OJ; Johnson GA
J Neurooncol; 2016 Jan; 126(2):243-51. PubMed ID: 26511492
[TBL] [Abstract][Full Text] [Related]
28. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
[TBL] [Abstract][Full Text] [Related]
29. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
Galanis E; Bateman A; Johnson K; Diaz RM; James CD; Vile R; Russell SJ
Hum Gene Ther; 2001 May; 12(7):811-21. PubMed ID: 11339897
[TBL] [Abstract][Full Text] [Related]
30. Cre/loxP-regulated transgenic zebrafish model for neural progenitor-specific oncogenic Kras expression.
Seok SH; Na YR; Han JH; Kim TH; Jung H; Lee BH; Emelyanov A; Parinov S; Park JH
Cancer Sci; 2010 Jan; 101(1):149-54. PubMed ID: 19961491
[TBL] [Abstract][Full Text] [Related]
31. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
[TBL] [Abstract][Full Text] [Related]
32. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
[TBL] [Abstract][Full Text] [Related]
33. Development of a novel mouse glioma model using lentiviral vectors.
Marumoto T; Tashiro A; Friedmann-Morvinski D; Scadeng M; Soda Y; Gage FH; Verma IM
Nat Med; 2009 Jan; 15(1):110-6. PubMed ID: 19122659
[TBL] [Abstract][Full Text] [Related]
34. Lentiviral Vector Induced Modeling of High-Grade Spinal Cord Glioma in Minipigs.
Tora MS; Texakalidis P; Neill S; Wetzel J; Rindler RS; Hardcastle N; Nagarajan PP; Krasnopeyev A; Roach C; James R; Bruce JN; Canoll P; Federici T; Oshinski JN; Boulis NM
Sci Rep; 2020 Mar; 10(1):5291. PubMed ID: 32210315
[TBL] [Abstract][Full Text] [Related]
35. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
36. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.
Miletic H; Fischer YH; Neumann H; Hans V; Stenzel W; Giroglou T; Hermann M; Deckert M; Von Laer D
Hum Gene Ther; 2004 Nov; 15(11):1091-100. PubMed ID: 15610609
[TBL] [Abstract][Full Text] [Related]
37. Development of therapeutics for high grade gliomas using orthotopic rodent models.
Frosina G
Curr Med Chem; 2013; 20(26):3272-99. PubMed ID: 23521683
[TBL] [Abstract][Full Text] [Related]
38. Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.
Kim Y; Hong HH; Lachat Y; Clayton NP; Devereux TR; Melnick RL; Hegi ME; Sills RC
Toxicol Pathol; 2005; 33(3):307-12. PubMed ID: 15814359
[TBL] [Abstract][Full Text] [Related]
39. PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli.
Abe T; Terada K; Wakimoto H; Inoue R; Tyminski E; Bookstein R; Basilion JP; Chiocca EA
Cancer Res; 2003 May; 63(9):2300-5. PubMed ID: 12727853
[TBL] [Abstract][Full Text] [Related]
40. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.
Lindberg N; Kastemar M; Olofsson T; Smits A; Uhrbom L
Oncogene; 2009 Jun; 28(23):2266-75. PubMed ID: 19421151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]